CannaCompare

Meta-analysis · 2026

Nabiximols in Multiple Sclerosis: Beyond Spasticity-An Exploratory Systematic Review and Meta-Analysis of Symptomatic Outcomes.

Cannabis formulations

Kleiner D, Horváth IL, Mátis D, Nagy R, Gergő D, Lugosi K, Fazekas G, Fehérvári P, Hegyi P, Csupor D.

Study design
Meta-analysis
Population / model
Human
Published
2026-06-25
Journal
Medical sciences (Basel, Switzerland)

From the author abstract

“However, the evidence certainty was low to very low, and these findings should be considered exploratory.”

A short attributed excerpt. Read the full abstract and original paper for methods, results and limitations.

Read on PubMed ↗Full text in PMC ↗Publisher / DOI ↗
Keep in your notebook →

Figures from the paper

Figure 1 Flow diagram of study identification and selection based on PRISMA 2020 guidelines [12].Kleiner D, Horváth IL, Mátis D, Nagy R, Gergő D, Lugosi K, Fazekas G, Fehérvári P, Hegyi P, Csupor D. Medical sciences (Basel, Switzerland) (2026). Original figure · CC BY · Resized for display.
Figure 2 Effects of nabiximols on spasm quality. The meta-analysis of studies shows a statistically significant effect of nabiximols on spasm quality (p = 0.01). (SE: standard error) [38,41,46,49,50].Kleiner D, Horváth IL, Mátis D, Nagy R, Gergő D, Lugosi K, Fazekas G, Fehérvári P, Hegyi P, Csupor D. Medical sciences (Basel, Switzerland) (2026). Original figure · CC BY · Resized for display.
Citation and indexing details

PMID 42506315 · PMC13413933

Publication types: Journal Article; Systematic Review; Meta-Analysis

Topic tags: Neurology

Metadata checked 2026-11-04. Study design and model tags follow indexing and explicit abstract terms. Citation counts are not evidence of benefit. An available full text does not by itself permit image reuse.